{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/mecasermin.json","peptide":{"slug":"mecasermin","name":"Mecasermin","url":"https://peptidescanner.com/peptides/mecasermin/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":32,"entries":[{"objectId":"story:fda-drugs-bla021839:v1","state":"current","stateChangedAt":"2026-11-17","title":"Drugs@FDA application BLA021839","domain":"Regulatory","dateInSource":"2005-08-30","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/fda-drugs-bla021839/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#fda-drugs-bla021839-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#fda-drugs-bla021839-v1","contentSha256":"a3fc3323bb9883fd735d6b943d3735afad70743fd93abbbbcc772ba1234fd3f5"},{"objectId":"story:federal-register-97-10541:v1","state":"current","stateChangedAt":"2026-11-17","title":"Federal Register notice 97-10541","domain":"Regulatory","dateInSource":"1997-04-23","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/federal-register-97-10541/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#federal-register-97-10541-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#federal-register-97-10541-v1","contentSha256":"ae0be17835ebd7cd96b39debde0261e128ebdacaea7bd80b1b3eb7b64ee4ad34"},{"objectId":"story:federal-register-98-7053:v1","state":"current","stateChangedAt":"2026-11-17","title":"Federal Register notice 98-7053","domain":"Regulatory","dateInSource":"1998-03-19","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/federal-register-98-7053/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#federal-register-98-7053-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#federal-register-98-7053-v1","contentSha256":"097b79e52db0279444f06ee1649dc5dd1933e1b381492f5d7da51d241667bd86"},{"objectId":"story:federal-register-e6-12571:v1","state":"current","stateChangedAt":"2026-11-17","title":"Federal Register notice E6-12571","domain":"Regulatory","dateInSource":"2006-08-03","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/federal-register-e6-12571/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#federal-register-e6-12571-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#federal-register-e6-12571-v1","contentSha256":"16022c7bf1c788dde0730e81f48b20f377ac4ba0a1df9b336f9b3057a24ad6f1"},{"objectId":"story:federal-register-e6-9138:v1","state":"current","stateChangedAt":"2026-11-17","title":"Federal Register notice E6-9138","domain":"Regulatory","dateInSource":"2006-06-13","publishedAt":"2026-11-17","humanUrl":"https://peptidescanner.com/stories/federal-register-e6-9138/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#federal-register-e6-9138-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#federal-register-e6-9138-v1","contentSha256":"a9c132cda7d5341f89abaf0db9b601f3b7caef8f9b9581df76ae327cb92fe4f3"},{"objectId":"story:clinicaltrials-gov-nct00516386-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00516386","domain":"Clinical trials","dateInSource":"2021-11-18","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00516386-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct00516386-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct00516386-mecasermin-v1","contentSha256":"aad1d83917321c96451f91812c6426a8353d3a2b5960c055715ec58c50ac08e0"},{"objectId":"story:clinicaltrials-gov-nct00571727-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00571727","domain":"Clinical trials","dateInSource":"2023-07-06","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00571727-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct00571727-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct00571727-mecasermin-v1","contentSha256":"6fa02f97774b9fd52798f21fc45ec6fe4b229f533f72605bb6ab42bbe1e729a8"},{"objectId":"story:clinicaltrials-gov-nct00903110-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT00903110","domain":"Clinical trials","dateInSource":"2026-02-06","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00903110-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct00903110-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct00903110-mecasermin-v1","contentSha256":"fd9e74ce5ef749a5dd64dda9f99d5e96b3709b124a5a9b80e75164a80909d3e1"},{"objectId":"story:clinicaltrials-gov-nct01406444-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01406444","domain":"Clinical trials","dateInSource":"2020-07-17","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01406444-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01406444-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct01406444-mecasermin-v1","contentSha256":"727d122dbf992f3ca562e124149872a3cc919b2a3cd3680839c604add87d5a3b"},{"objectId":"story:clinicaltrials-gov-nct01438086-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01438086","domain":"Clinical trials","dateInSource":"2017-03-30","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01438086-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01438086-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct01438086-mecasermin-v1","contentSha256":"d2d02f6b64faddc950587e42807fc5990883aad3fdbf3fe8d07512a6104ddd1a"},{"objectId":"story:clinicaltrials-gov-nct01446783-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01446783","domain":"Clinical trials","dateInSource":"2012-11-20","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01446783-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01446783-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct01446783-mecasermin-v1","contentSha256":"f3d01a7fd4595ffc67bf203d7db238898a033933f846aa70e658aaf65a3e0450"},{"objectId":"story:clinicaltrials-gov-nct01588093-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01588093","domain":"Clinical trials","dateInSource":"2012-04-30","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01588093-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01588093-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct01588093-mecasermin-v1","contentSha256":"a6bf0e0ccbfb321a89701e0382cc01b23388977ba2ea7dc5e52e117d3b32c860"},{"objectId":"story:clinicaltrials-gov-nct01777542-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT01777542","domain":"Clinical trials","dateInSource":"2018-03-26","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01777542-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01777542-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct01777542-mecasermin-v1","contentSha256":"759dab1ea300c56bca205b24f8589e7fd6d2e82c8c276339d48382c9e59fd3df"},{"objectId":"story:clinicaltrials-gov-nct02636270-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"ClinicalTrials.gov record NCT02636270","domain":"Clinical trials","dateInSource":"2024-02-28","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02636270-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct02636270-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#clinicaltrials-gov-nct02636270-mecasermin-v1","contentSha256":"0ef8cc2b42498a6b3b90f1ca78ab9f8916450baeefbe56bf30022a9445723f7a"},{"objectId":"story:pubmed-pmid-10576957-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"USAN Council. List No. 419. New names. Mecasermin.","domain":"Literature metadata","dateInSource":"2007-11-15","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-10576957-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-10576957-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-10576957-mecasermin-v1","contentSha256":"656c53c8b1b125ee5e04ea6f8423c5013e9daa9b5fda258ddbdc3b2c1ebaf27f"},{"objectId":"story:pubmed-pmid-15777106-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.","domain":"Literature metadata","dateInSource":"2018-10-25","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-15777106-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-15777106-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-15777106-mecasermin-v1","contentSha256":"d502107a610f455a73b91cd1ed7cfa1cc0f6a95516d3869e08f7f3b673ac6372"},{"objectId":"story:pubmed-pmid-16625824-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Mecasermin Tercica.","domain":"Literature metadata","dateInSource":"2007-11-15","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-16625824-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-16625824-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-16625824-mecasermin-v1","contentSha256":"bb78bab4211f1f3746c520aa5f0fe83dd11ba1c09b378c95f56dbf023af696d1"},{"objectId":"story:pubmed-pmid-17380212-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Mecasermin rinfabate.","domain":"Literature metadata","dateInSource":"2017-04-27","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-17380212-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-17380212-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-17380212-mecasermin-v1","contentSha256":"59a61a1eff03995b9fae267daf0f1f2fa1e135826fae4ccceb701ae5c8c6c855"},{"objectId":"story:pubmed-pmid-18363546-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX.","domain":"Literature metadata","dateInSource":"2019-11-10","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-18363546-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-18363546-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-18363546-mecasermin-v1","contentSha256":"b4ab5db51adba1b5ada0918a31311481eee3286c0a9d6f67804a36c9c40da020"},{"objectId":"story:pubmed-pmid-18481900-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Mecasermin.","domain":"Literature metadata","dateInSource":"2022-03-31","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-18481900-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-18481900-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-18481900-mecasermin-v1","contentSha256":"460bb006ef981e1bc9ca0ebf6cc073b81d06da79cd291f7164c934c0302d42ea"},{"objectId":"story:pubmed-pmid-19198769-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Mecasermin (recombinant human insulin-like growth factor I).","domain":"Literature metadata","dateInSource":"2012-11-15","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-19198769-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-19198769-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-19198769-mecasermin-v1","contentSha256":"8cd2930ac3710f3a4c5fee2f9544732d10110c821e137d221be07492d254ef36"},{"objectId":"story:pubmed-pmid-19663134-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Allergic reaction to mecasermin.","domain":"Literature metadata","dateInSource":"2009-08-11","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-19663134-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-19663134-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-19663134-mecasermin-v1","contentSha256":"f416556440946d096c638fbc02fc55f27dec3d9d90b7a9c487145c0d3401e28f"},{"objectId":"story:pubmed-pmid-19707272-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency.","domain":"Literature metadata","dateInSource":"2022-03-10","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-19707272-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-19707272-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-19707272-mecasermin-v1","contentSha256":"2fb51a497dcc5ad994552372cdf6a3763b400db300ef1cca66127a1da9da3b9f"},{"objectId":"story:pubmed-pmid-22986916-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Postprandial hyperglycemia corrected by IGF-I (Increlex®) in Laron syndrome.","domain":"Literature metadata","dateInSource":"2016-05-19","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-22986916-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-22986916-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-22986916-mecasermin-v1","contentSha256":"77ea2888d821f3327fd447f88967094e4b74f5b6b768bbe7d8fa318e2fbe9078"},{"objectId":"story:pubmed-pmid-25843163-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Desensitization to mecasermin in an insulin-like growth factor 1-deficient patient.","domain":"Literature metadata","dateInSource":"2015-05-29","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-25843163-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-25843163-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-25843163-mecasermin-v1","contentSha256":"2234cd3b0a927372613a450ba38870dc2284a6dbf4c9a0691b33f2cd27f2721f"},{"objectId":"story:pubmed-pmid-26339260-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Recombinant production of mecasermin in E. coli expression system.","domain":"Literature metadata","dateInSource":"2020-09-30","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-26339260-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-26339260-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-26339260-mecasermin-v1","contentSha256":"f0baf26cc7fd6e971068a494b0b9bfa26e81f3140a041a9d82cdc177caecc136"},{"objectId":"story:pubmed-pmid-29695048-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature.","domain":"Literature metadata","dateInSource":"2019-01-24","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29695048-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-29695048-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-29695048-mecasermin-v1","contentSha256":"d106b1f5a44337473c696d1d1d9b8ccdd6e0e9201ed98552efcc0168684862ca"},{"objectId":"story:pubmed-pmid-29750649-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Cardiac examination in children with Laron syndrome undergoing mecasermin therapy.","domain":"Literature metadata","dateInSource":"2021-02-13","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29750649-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-29750649-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-29750649-mecasermin-v1","contentSha256":"bcab93ccd40caa0da4707d88692f1b7e1b32a13d411a1c43231687c6a024e7a3"},{"objectId":"story:pubmed-pmid-32692415-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Efficient process development for high-level production, purification, formulation, and characterization of recombinant mecasermin in Escherichia coli.","domain":"Literature metadata","dateInSource":"2021-09-29","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-32692415-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-32692415-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-32692415-mecasermin-v1","contentSha256":"912c521caaebf296222b2de0494c133126de7d3633ae1e58ea8889885cb1366d"},{"objectId":"story:pubmed-pmid-36269524-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Alterations in Stem Cell Populations in IGF-1 Deficient Pediatric Patients Subjected to Mecasermin (Increlex) Treatment.","domain":"Literature metadata","dateInSource":"2026-01-27","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-36269524-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-36269524-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-36269524-mecasermin-v1","contentSha256":"2029be088baa5c8f641d34420e97aaa482c9259c96c026a0a194b9e0e3371381"},{"objectId":"story:pubmed-pmid-36479333-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Mecasermin for primary insulin-like growth factor-1 deficiency.","domain":"Literature metadata","dateInSource":"2022-12-10","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-36479333-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-36479333-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-36479333-mecasermin-v1","contentSha256":"3cadca40b053b2e6edf07bd11b3e392d3981b565044ecd878ade95d4baa9d800"},{"objectId":"story:pubmed-pmid-41174329-mecasermin:v1","state":"current","stateChangedAt":"2026-11-16","title":"Mecasermin for the treatment of Rett Syndrome: a systematic review.","domain":"Literature metadata","dateInSource":"2026-11-05","publishedAt":"2026-11-16","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41174329-mecasermin/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-41174329-mecasermin-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/mecasermin.md#pubmed-pmid-41174329-mecasermin-v1","contentSha256":"2a0d5b452043aacdd5c18113b5e93bf62e48d7b1b0d116cc3fb7f49306850090"}]}
